zintick

← Oric Pharmaceuticals (ORIC)

Oric Pharmaceuticals SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • 8-KOct. 23, 2026, 8 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedORIC Pharmaceuticals Presents Enozertinib Phase 1b Data at ESMO 2026 Showing 84% Systemic ORR and Plans Phase 3 Redwood-1 Start in 1H 2027

  • 8-KAug. 3, 2026, 4:10 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

  • 8-KJuly 30, 2026, 4:49 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Financial statements and exhibits